Flagship Pioneering, a scientific innovation engine for transformative platforms and products, announced the launch of Serif Biomedicines, a biotechnology company pioneering Modified DNA as a new class of medicines. Company emerges following five years of platform development and with an initial commitment of $50 million from Flagship Pioneering.